The New Cannabinoid on the Block: CBG
The potent power of CBG is a hot topic, and American hemp farmers have been anxiously awaiting the release of reliable high-CBG genetics. While THC and CBD have long been the cannabinoids of focus, researchers and hemp enthusiasts are now teaming up to better understand CBG. And hemp genetics experts are aggressively breeding new strains that deliver high yields of CBG over other cannabinoids.
One hemp breeder, Matthias Ghidossi, founder of Swiss Cannabinoid, has been working for years to cultivate his own terpene and cannabinoid-rich crops. Through a science-based approach, he surveyed thousands of hemp varietals. In his quest, it became clear that the varietal of choice should not only be terpene-focused, but also CBG dominant.
“CBG is a cannabinoid we chose to focus on due to its powerful efficacy in early trials. Over the past few years, more and more research has been conducted to understand the value of CBG. The early results of clinical testing in Europe are creating a lot of excitement in the fields of science and medicine,” said Matthias Ghidossi.
Bodhi Urban, CEO of High Grade Hemp Seed, shared, “At High Grade we have focused our breeding program and partnerships to ensure farmers can grow proven, strong and diverse genetics. That’s one of the reasons we decided to work with Swiss Cannabinoid as a true genetics partner. Paving the way in CBG has been a logical next step – both in advancing the agricultural industry and also in improving the availability of CBG products to U.S. consumers.”
From Hemp Industry Daily